Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals-Reference-Cited by-同舟云学术

Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals

Published:2021-08 Issue: Volume:122 Page:102682
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Lingel Holger,Meltendorf Stefan,Billing Ulrike,Thurm Christoph,Vogel Katrin,Majer Christiane,Prätsch Florian,Roggenbuck Dirk,Heuft Hans-Gert,Hachenberg Thomas,Feist Eugen,Reinhold Dirk,Brunner-Weinzierl Monika C.

Funder

Deutsche Forschungsgemeinschaft

Bundesministerium für Bildung und Forschung

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

3. Autoantibodies against type I IFNs in patients with life-threatening COVID-19;Bastard;Science,2020

4. Lupus anticoagulant and abnormal coagulation tests in patients with covid-19;Bowles;N. Engl. J. Med.,2020

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candida and Long Covid: Mannan Not from Heaven;Qeios;2024-06-24

2. Challenges and opportunities in long COVID research;Immunity;2024-06

3. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long COVID;Medical Review;2024-05-27

4. Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms;2024-05-08

5. The development of anticyclic citrullinated peptide (anti‐CCP) antibody following severe COVID‐19;Immunity, Inflammation and Disease;2024-05